2147 Search Results


94
ATCC atcc baa 2147 type strain
Atcc Baa 2147 Type Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2147/pm36178765-39-23-23?v=ATCC
Average 94 stars, based on 1 article reviews
atcc baa 2147 type strain - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

93
BOC Sciences hydroxy d l kynurenine
Hydroxy D L Kynurenine, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2147/pm41129589-161-0-2?v=BOC+Sciences
Average 93 stars, based on 1 article reviews
hydroxy d l kynurenine - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

94
ATCC section 19
Section 19, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2147/10__2147_slash_ott__s366605-55-18-52?v=ATCC
Average 94 stars, based on 1 article reviews
section 19 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

80
Santa Cruz Biotechnology hl60 nuclear extract
Figure 6 Binding of AMY-1 to C-MYC. The whole length and various segments of the AMY-1 cDNA were expressed in yeast, in bacteria or in mammalian cells and the binding of the proteins to C-MYC was verified. (A) The whole length, the N-terminal half (ES; amino acids 1–63), the C-terminal deletion (EH; amino acids 1–89), the C-terminal half (SX; amino acids 64–104) and the C-terminal end (HX; amino acids 90–104) segments, schematically shown in the figure, were cloned in pGADGH and expressed in the S. cerevisiae HF7C cells (Clontech) transformed with pGBT9-c-myc. After incubation in liquid medium or on filters, b-galactosidase activity was assayed. (B) The wild-type and deletion mutants of AMY-1 fused to thioredoxin (Trx) and (His)6, as well as Trx-(His)6 alone, were expressed in E. coli and subjected to in vitro binding assays. The 1/20 volume of <t>HL60</t> cell extract used for binding reaction was electrophoresed in the same gel in parallel (lane HL60). (C) The wild-type AMY-1 and the pocket domain of p107 which was fused to GST, as well as GST alone, were expressed in E. coli, purified, and subjected to in vitro binding assay by use of 35S-labelled C-MYC which was synthesized in vitro in reticulocyte lysate. The 1/100 volume of 35S-C-MYC used for the binding reaction was electrophoresed in the same gel in parallel (lane C-MYC). (D) The extract of AM416 cells, constitutively expressing AMY-1-HA, was first immunoprecipitated with an anti-HA antibody (a-HA) or nonspecific mouse IgG (IgG). The precipitates were then separated in a 7.5% polyacrylamide gel containing SDS, blotted on to a filter and reacted with the anti-HA antibody (a-HA) or an anti-C-MYC antibody (a-C-MYC). The 1/5 or 1/20 volume of AM416 cell extract used for binding reaction were electrophoresed in parallel in the same gel (lanes AM416 on left and right, respectively). (E) The extract of HeLa cells was analysed as in (D) using the anti-C-MYC antibody and an anti-AMY-1 antibody (a-AMY-1). The 1/10 or 1/50 volumes of HeLa cell extract used for binding reaction were electrophoresed in parallel in the same gel (left or right of lane HeLa, respectively). (F) The wild-type and various deletion mutants of c- myc were expressed in the yeast cells transformed with pGBT9-AMY-1, and the interaction between myc proteins and AMY-1 was tested as in (A).
Hl60 Nuclear Extract, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 80/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2147/pm09797456-81-45-14?v=Santa+Cruz+Biotechnology
Average 80 stars, based on 1 article reviews
hl60 nuclear extract - by Bioz Stars, 2026-07
80/100 stars
  Buy from Supplier

90
Huntsman International LLC surfactant 2147
Figure 6 Binding of AMY-1 to C-MYC. The whole length and various segments of the AMY-1 cDNA were expressed in yeast, in bacteria or in mammalian cells and the binding of the proteins to C-MYC was verified. (A) The whole length, the N-terminal half (ES; amino acids 1–63), the C-terminal deletion (EH; amino acids 1–89), the C-terminal half (SX; amino acids 64–104) and the C-terminal end (HX; amino acids 90–104) segments, schematically shown in the figure, were cloned in pGADGH and expressed in the S. cerevisiae HF7C cells (Clontech) transformed with pGBT9-c-myc. After incubation in liquid medium or on filters, b-galactosidase activity was assayed. (B) The wild-type and deletion mutants of AMY-1 fused to thioredoxin (Trx) and (His)6, as well as Trx-(His)6 alone, were expressed in E. coli and subjected to in vitro binding assays. The 1/20 volume of <t>HL60</t> cell extract used for binding reaction was electrophoresed in the same gel in parallel (lane HL60). (C) The wild-type AMY-1 and the pocket domain of p107 which was fused to GST, as well as GST alone, were expressed in E. coli, purified, and subjected to in vitro binding assay by use of 35S-labelled C-MYC which was synthesized in vitro in reticulocyte lysate. The 1/100 volume of 35S-C-MYC used for the binding reaction was electrophoresed in the same gel in parallel (lane C-MYC). (D) The extract of AM416 cells, constitutively expressing AMY-1-HA, was first immunoprecipitated with an anti-HA antibody (a-HA) or nonspecific mouse IgG (IgG). The precipitates were then separated in a 7.5% polyacrylamide gel containing SDS, blotted on to a filter and reacted with the anti-HA antibody (a-HA) or an anti-C-MYC antibody (a-C-MYC). The 1/5 or 1/20 volume of AM416 cell extract used for binding reaction were electrophoresed in parallel in the same gel (lanes AM416 on left and right, respectively). (E) The extract of HeLa cells was analysed as in (D) using the anti-C-MYC antibody and an anti-AMY-1 antibody (a-AMY-1). The 1/10 or 1/50 volumes of HeLa cell extract used for binding reaction were electrophoresed in parallel in the same gel (left or right of lane HeLa, respectively). (F) The wild-type and various deletion mutants of c- myc were expressed in the yeast cells transformed with pGBT9-AMY-1, and the interaction between myc proteins and AMY-1 was tested as in (A).
Surfactant 2147, supplied by Huntsman International LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2147/us12241011-424-0-4?v=Huntsman+International+LLC
Average 90 stars, based on 1 article reviews
surfactant 2147 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
VDM Biochemicals cno (10 mg/kg/d)
Figure 6 Binding of AMY-1 to C-MYC. The whole length and various segments of the AMY-1 cDNA were expressed in yeast, in bacteria or in mammalian cells and the binding of the proteins to C-MYC was verified. (A) The whole length, the N-terminal half (ES; amino acids 1–63), the C-terminal deletion (EH; amino acids 1–89), the C-terminal half (SX; amino acids 64–104) and the C-terminal end (HX; amino acids 90–104) segments, schematically shown in the figure, were cloned in pGADGH and expressed in the S. cerevisiae HF7C cells (Clontech) transformed with pGBT9-c-myc. After incubation in liquid medium or on filters, b-galactosidase activity was assayed. (B) The wild-type and deletion mutants of AMY-1 fused to thioredoxin (Trx) and (His)6, as well as Trx-(His)6 alone, were expressed in E. coli and subjected to in vitro binding assays. The 1/20 volume of <t>HL60</t> cell extract used for binding reaction was electrophoresed in the same gel in parallel (lane HL60). (C) The wild-type AMY-1 and the pocket domain of p107 which was fused to GST, as well as GST alone, were expressed in E. coli, purified, and subjected to in vitro binding assay by use of 35S-labelled C-MYC which was synthesized in vitro in reticulocyte lysate. The 1/100 volume of 35S-C-MYC used for the binding reaction was electrophoresed in the same gel in parallel (lane C-MYC). (D) The extract of AM416 cells, constitutively expressing AMY-1-HA, was first immunoprecipitated with an anti-HA antibody (a-HA) or nonspecific mouse IgG (IgG). The precipitates were then separated in a 7.5% polyacrylamide gel containing SDS, blotted on to a filter and reacted with the anti-HA antibody (a-HA) or an anti-C-MYC antibody (a-C-MYC). The 1/5 or 1/20 volume of AM416 cell extract used for binding reaction were electrophoresed in parallel in the same gel (lanes AM416 on left and right, respectively). (E) The extract of HeLa cells was analysed as in (D) using the anti-C-MYC antibody and an anti-AMY-1 antibody (a-AMY-1). The 1/10 or 1/50 volumes of HeLa cell extract used for binding reaction were electrophoresed in parallel in the same gel (left or right of lane HeLa, respectively). (F) The wild-type and various deletion mutants of c- myc were expressed in the yeast cells transformed with pGBT9-AMY-1, and the interaction between myc proteins and AMY-1 was tested as in (A).
Cno (10 Mg/Kg/D), supplied by VDM Biochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2147/pmc05983349-598-13-16?v=VDM+Biochemicals
Average 90 stars, based on 1 article reviews
cno (10 mg/kg/d) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Arrow Engineering sequestering agent arroquest 2147
Figure 6 Binding of AMY-1 to C-MYC. The whole length and various segments of the AMY-1 cDNA were expressed in yeast, in bacteria or in mammalian cells and the binding of the proteins to C-MYC was verified. (A) The whole length, the N-terminal half (ES; amino acids 1–63), the C-terminal deletion (EH; amino acids 1–89), the C-terminal half (SX; amino acids 64–104) and the C-terminal end (HX; amino acids 90–104) segments, schematically shown in the figure, were cloned in pGADGH and expressed in the S. cerevisiae HF7C cells (Clontech) transformed with pGBT9-c-myc. After incubation in liquid medium or on filters, b-galactosidase activity was assayed. (B) The wild-type and deletion mutants of AMY-1 fused to thioredoxin (Trx) and (His)6, as well as Trx-(His)6 alone, were expressed in E. coli and subjected to in vitro binding assays. The 1/20 volume of <t>HL60</t> cell extract used for binding reaction was electrophoresed in the same gel in parallel (lane HL60). (C) The wild-type AMY-1 and the pocket domain of p107 which was fused to GST, as well as GST alone, were expressed in E. coli, purified, and subjected to in vitro binding assay by use of 35S-labelled C-MYC which was synthesized in vitro in reticulocyte lysate. The 1/100 volume of 35S-C-MYC used for the binding reaction was electrophoresed in the same gel in parallel (lane C-MYC). (D) The extract of AM416 cells, constitutively expressing AMY-1-HA, was first immunoprecipitated with an anti-HA antibody (a-HA) or nonspecific mouse IgG (IgG). The precipitates were then separated in a 7.5% polyacrylamide gel containing SDS, blotted on to a filter and reacted with the anti-HA antibody (a-HA) or an anti-C-MYC antibody (a-C-MYC). The 1/5 or 1/20 volume of AM416 cell extract used for binding reaction were electrophoresed in parallel in the same gel (lanes AM416 on left and right, respectively). (E) The extract of HeLa cells was analysed as in (D) using the anti-C-MYC antibody and an anti-AMY-1 antibody (a-AMY-1). The 1/10 or 1/50 volumes of HeLa cell extract used for binding reaction were electrophoresed in parallel in the same gel (left or right of lane HeLa, respectively). (F) The wild-type and various deletion mutants of c- myc were expressed in the yeast cells transformed with pGBT9-AMY-1, and the interaction between myc proteins and AMY-1 was tested as in (A).
Sequestering Agent Arroquest 2147, supplied by Arrow Engineering, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2147/us07033669-207-17-44?v=Arrow+Engineering
Average 90 stars, based on 1 article reviews
sequestering agent arroquest 2147 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Predictive Science Inc global coronal mhd model predictive mas model for carrington rotation 2147
Figure 6 Binding of AMY-1 to C-MYC. The whole length and various segments of the AMY-1 cDNA were expressed in yeast, in bacteria or in mammalian cells and the binding of the proteins to C-MYC was verified. (A) The whole length, the N-terminal half (ES; amino acids 1–63), the C-terminal deletion (EH; amino acids 1–89), the C-terminal half (SX; amino acids 64–104) and the C-terminal end (HX; amino acids 90–104) segments, schematically shown in the figure, were cloned in pGADGH and expressed in the S. cerevisiae HF7C cells (Clontech) transformed with pGBT9-c-myc. After incubation in liquid medium or on filters, b-galactosidase activity was assayed. (B) The wild-type and deletion mutants of AMY-1 fused to thioredoxin (Trx) and (His)6, as well as Trx-(His)6 alone, were expressed in E. coli and subjected to in vitro binding assays. The 1/20 volume of <t>HL60</t> cell extract used for binding reaction was electrophoresed in the same gel in parallel (lane HL60). (C) The wild-type AMY-1 and the pocket domain of p107 which was fused to GST, as well as GST alone, were expressed in E. coli, purified, and subjected to in vitro binding assay by use of 35S-labelled C-MYC which was synthesized in vitro in reticulocyte lysate. The 1/100 volume of 35S-C-MYC used for the binding reaction was electrophoresed in the same gel in parallel (lane C-MYC). (D) The extract of AM416 cells, constitutively expressing AMY-1-HA, was first immunoprecipitated with an anti-HA antibody (a-HA) or nonspecific mouse IgG (IgG). The precipitates were then separated in a 7.5% polyacrylamide gel containing SDS, blotted on to a filter and reacted with the anti-HA antibody (a-HA) or an anti-C-MYC antibody (a-C-MYC). The 1/5 or 1/20 volume of AM416 cell extract used for binding reaction were electrophoresed in parallel in the same gel (lanes AM416 on left and right, respectively). (E) The extract of HeLa cells was analysed as in (D) using the anti-C-MYC antibody and an anti-AMY-1 antibody (a-AMY-1). The 1/10 or 1/50 volumes of HeLa cell extract used for binding reaction were electrophoresed in parallel in the same gel (left or right of lane HeLa, respectively). (F) The wild-type and various deletion mutants of c- myc were expressed in the yeast cells transformed with pGBT9-AMY-1, and the interaction between myc proteins and AMY-1 was tested as in (A).
Global Coronal Mhd Model Predictive Mas Model For Carrington Rotation 2147, supplied by Predictive Science Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2147/10__3389_slash_fspas__2016__00001-175-14-17?v=Predictive+Science+Inc
Average 90 stars, based on 1 article reviews
global coronal mhd model predictive mas model for carrington rotation 2147 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Harlan Laboratories bcm-2147 human cancer-in-mice xenografts
Figure 6 Binding of AMY-1 to C-MYC. The whole length and various segments of the AMY-1 cDNA were expressed in yeast, in bacteria or in mammalian cells and the binding of the proteins to C-MYC was verified. (A) The whole length, the N-terminal half (ES; amino acids 1–63), the C-terminal deletion (EH; amino acids 1–89), the C-terminal half (SX; amino acids 64–104) and the C-terminal end (HX; amino acids 90–104) segments, schematically shown in the figure, were cloned in pGADGH and expressed in the S. cerevisiae HF7C cells (Clontech) transformed with pGBT9-c-myc. After incubation in liquid medium or on filters, b-galactosidase activity was assayed. (B) The wild-type and deletion mutants of AMY-1 fused to thioredoxin (Trx) and (His)6, as well as Trx-(His)6 alone, were expressed in E. coli and subjected to in vitro binding assays. The 1/20 volume of <t>HL60</t> cell extract used for binding reaction was electrophoresed in the same gel in parallel (lane HL60). (C) The wild-type AMY-1 and the pocket domain of p107 which was fused to GST, as well as GST alone, were expressed in E. coli, purified, and subjected to in vitro binding assay by use of 35S-labelled C-MYC which was synthesized in vitro in reticulocyte lysate. The 1/100 volume of 35S-C-MYC used for the binding reaction was electrophoresed in the same gel in parallel (lane C-MYC). (D) The extract of AM416 cells, constitutively expressing AMY-1-HA, was first immunoprecipitated with an anti-HA antibody (a-HA) or nonspecific mouse IgG (IgG). The precipitates were then separated in a 7.5% polyacrylamide gel containing SDS, blotted on to a filter and reacted with the anti-HA antibody (a-HA) or an anti-C-MYC antibody (a-C-MYC). The 1/5 or 1/20 volume of AM416 cell extract used for binding reaction were electrophoresed in parallel in the same gel (lanes AM416 on left and right, respectively). (E) The extract of HeLa cells was analysed as in (D) using the anti-C-MYC antibody and an anti-AMY-1 antibody (a-AMY-1). The 1/10 or 1/50 volumes of HeLa cell extract used for binding reaction were electrophoresed in parallel in the same gel (left or right of lane HeLa, respectively). (F) The wild-type and various deletion mutants of c- myc were expressed in the yeast cells transformed with pGBT9-AMY-1, and the interaction between myc proteins and AMY-1 was tested as in (A).
Bcm 2147 Human Cancer In Mice Xenografts, supplied by Harlan Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2147/pmc03770306-116-6-13?v=Harlan+Laboratories
Average 90 stars, based on 1 article reviews
bcm-2147 human cancer-in-mice xenografts - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Arrow Engineering arroquest 2147
Figure 6 Binding of AMY-1 to C-MYC. The whole length and various segments of the AMY-1 cDNA were expressed in yeast, in bacteria or in mammalian cells and the binding of the proteins to C-MYC was verified. (A) The whole length, the N-terminal half (ES; amino acids 1–63), the C-terminal deletion (EH; amino acids 1–89), the C-terminal half (SX; amino acids 64–104) and the C-terminal end (HX; amino acids 90–104) segments, schematically shown in the figure, were cloned in pGADGH and expressed in the S. cerevisiae HF7C cells (Clontech) transformed with pGBT9-c-myc. After incubation in liquid medium or on filters, b-galactosidase activity was assayed. (B) The wild-type and deletion mutants of AMY-1 fused to thioredoxin (Trx) and (His)6, as well as Trx-(His)6 alone, were expressed in E. coli and subjected to in vitro binding assays. The 1/20 volume of <t>HL60</t> cell extract used for binding reaction was electrophoresed in the same gel in parallel (lane HL60). (C) The wild-type AMY-1 and the pocket domain of p107 which was fused to GST, as well as GST alone, were expressed in E. coli, purified, and subjected to in vitro binding assay by use of 35S-labelled C-MYC which was synthesized in vitro in reticulocyte lysate. The 1/100 volume of 35S-C-MYC used for the binding reaction was electrophoresed in the same gel in parallel (lane C-MYC). (D) The extract of AM416 cells, constitutively expressing AMY-1-HA, was first immunoprecipitated with an anti-HA antibody (a-HA) or nonspecific mouse IgG (IgG). The precipitates were then separated in a 7.5% polyacrylamide gel containing SDS, blotted on to a filter and reacted with the anti-HA antibody (a-HA) or an anti-C-MYC antibody (a-C-MYC). The 1/5 or 1/20 volume of AM416 cell extract used for binding reaction were electrophoresed in parallel in the same gel (lanes AM416 on left and right, respectively). (E) The extract of HeLa cells was analysed as in (D) using the anti-C-MYC antibody and an anti-AMY-1 antibody (a-AMY-1). The 1/10 or 1/50 volumes of HeLa cell extract used for binding reaction were electrophoresed in parallel in the same gel (left or right of lane HeLa, respectively). (F) The wild-type and various deletion mutants of c- myc were expressed in the yeast cells transformed with pGBT9-AMY-1, and the interaction between myc proteins and AMY-1 was tested as in (A).
Arroquest 2147, supplied by Arrow Engineering, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2147/us07033669-134-16-20?v=Arrow+Engineering
Average 90 stars, based on 1 article reviews
arroquest 2147 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Huntsman International LLC ethoxylated triethylenetetramine (teta) huntsman surfactant 2147
Figure 6 Binding of AMY-1 to C-MYC. The whole length and various segments of the AMY-1 cDNA were expressed in yeast, in bacteria or in mammalian cells and the binding of the proteins to C-MYC was verified. (A) The whole length, the N-terminal half (ES; amino acids 1–63), the C-terminal deletion (EH; amino acids 1–89), the C-terminal half (SX; amino acids 64–104) and the C-terminal end (HX; amino acids 90–104) segments, schematically shown in the figure, were cloned in pGADGH and expressed in the S. cerevisiae HF7C cells (Clontech) transformed with pGBT9-c-myc. After incubation in liquid medium or on filters, b-galactosidase activity was assayed. (B) The wild-type and deletion mutants of AMY-1 fused to thioredoxin (Trx) and (His)6, as well as Trx-(His)6 alone, were expressed in E. coli and subjected to in vitro binding assays. The 1/20 volume of <t>HL60</t> cell extract used for binding reaction was electrophoresed in the same gel in parallel (lane HL60). (C) The wild-type AMY-1 and the pocket domain of p107 which was fused to GST, as well as GST alone, were expressed in E. coli, purified, and subjected to in vitro binding assay by use of 35S-labelled C-MYC which was synthesized in vitro in reticulocyte lysate. The 1/100 volume of 35S-C-MYC used for the binding reaction was electrophoresed in the same gel in parallel (lane C-MYC). (D) The extract of AM416 cells, constitutively expressing AMY-1-HA, was first immunoprecipitated with an anti-HA antibody (a-HA) or nonspecific mouse IgG (IgG). The precipitates were then separated in a 7.5% polyacrylamide gel containing SDS, blotted on to a filter and reacted with the anti-HA antibody (a-HA) or an anti-C-MYC antibody (a-C-MYC). The 1/5 or 1/20 volume of AM416 cell extract used for binding reaction were electrophoresed in parallel in the same gel (lanes AM416 on left and right, respectively). (E) The extract of HeLa cells was analysed as in (D) using the anti-C-MYC antibody and an anti-AMY-1 antibody (a-AMY-1). The 1/10 or 1/50 volumes of HeLa cell extract used for binding reaction were electrophoresed in parallel in the same gel (left or right of lane HeLa, respectively). (F) The wild-type and various deletion mutants of c- myc were expressed in the yeast cells transformed with pGBT9-AMY-1, and the interaction between myc proteins and AMY-1 was tested as in (A).
Ethoxylated Triethylenetetramine (Teta) Huntsman Surfactant 2147, supplied by Huntsman International LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2147/us12195686-119-68-68?v=Huntsman+International+LLC
Average 90 stars, based on 1 article reviews
ethoxylated triethylenetetramine (teta) huntsman surfactant 2147 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
PASCO ps-2147 probe
Figure 6 Binding of AMY-1 to C-MYC. The whole length and various segments of the AMY-1 cDNA were expressed in yeast, in bacteria or in mammalian cells and the binding of the proteins to C-MYC was verified. (A) The whole length, the N-terminal half (ES; amino acids 1–63), the C-terminal deletion (EH; amino acids 1–89), the C-terminal half (SX; amino acids 64–104) and the C-terminal end (HX; amino acids 90–104) segments, schematically shown in the figure, were cloned in pGADGH and expressed in the S. cerevisiae HF7C cells (Clontech) transformed with pGBT9-c-myc. After incubation in liquid medium or on filters, b-galactosidase activity was assayed. (B) The wild-type and deletion mutants of AMY-1 fused to thioredoxin (Trx) and (His)6, as well as Trx-(His)6 alone, were expressed in E. coli and subjected to in vitro binding assays. The 1/20 volume of <t>HL60</t> cell extract used for binding reaction was electrophoresed in the same gel in parallel (lane HL60). (C) The wild-type AMY-1 and the pocket domain of p107 which was fused to GST, as well as GST alone, were expressed in E. coli, purified, and subjected to in vitro binding assay by use of 35S-labelled C-MYC which was synthesized in vitro in reticulocyte lysate. The 1/100 volume of 35S-C-MYC used for the binding reaction was electrophoresed in the same gel in parallel (lane C-MYC). (D) The extract of AM416 cells, constitutively expressing AMY-1-HA, was first immunoprecipitated with an anti-HA antibody (a-HA) or nonspecific mouse IgG (IgG). The precipitates were then separated in a 7.5% polyacrylamide gel containing SDS, blotted on to a filter and reacted with the anti-HA antibody (a-HA) or an anti-C-MYC antibody (a-C-MYC). The 1/5 or 1/20 volume of AM416 cell extract used for binding reaction were electrophoresed in parallel in the same gel (lanes AM416 on left and right, respectively). (E) The extract of HeLa cells was analysed as in (D) using the anti-C-MYC antibody and an anti-AMY-1 antibody (a-AMY-1). The 1/10 or 1/50 volumes of HeLa cell extract used for binding reaction were electrophoresed in parallel in the same gel (left or right of lane HeLa, respectively). (F) The wild-type and various deletion mutants of c- myc were expressed in the yeast cells transformed with pGBT9-AMY-1, and the interaction between myc proteins and AMY-1 was tested as in (A).
Ps 2147 Probe, supplied by PASCO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2147/pm29407714-82-18-21?v=PASCO
Average 90 stars, based on 1 article reviews
ps-2147 probe - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Figure 6 Binding of AMY-1 to C-MYC. The whole length and various segments of the AMY-1 cDNA were expressed in yeast, in bacteria or in mammalian cells and the binding of the proteins to C-MYC was verified. (A) The whole length, the N-terminal half (ES; amino acids 1–63), the C-terminal deletion (EH; amino acids 1–89), the C-terminal half (SX; amino acids 64–104) and the C-terminal end (HX; amino acids 90–104) segments, schematically shown in the figure, were cloned in pGADGH and expressed in the S. cerevisiae HF7C cells (Clontech) transformed with pGBT9-c-myc. After incubation in liquid medium or on filters, b-galactosidase activity was assayed. (B) The wild-type and deletion mutants of AMY-1 fused to thioredoxin (Trx) and (His)6, as well as Trx-(His)6 alone, were expressed in E. coli and subjected to in vitro binding assays. The 1/20 volume of HL60 cell extract used for binding reaction was electrophoresed in the same gel in parallel (lane HL60). (C) The wild-type AMY-1 and the pocket domain of p107 which was fused to GST, as well as GST alone, were expressed in E. coli, purified, and subjected to in vitro binding assay by use of 35S-labelled C-MYC which was synthesized in vitro in reticulocyte lysate. The 1/100 volume of 35S-C-MYC used for the binding reaction was electrophoresed in the same gel in parallel (lane C-MYC). (D) The extract of AM416 cells, constitutively expressing AMY-1-HA, was first immunoprecipitated with an anti-HA antibody (a-HA) or nonspecific mouse IgG (IgG). The precipitates were then separated in a 7.5% polyacrylamide gel containing SDS, blotted on to a filter and reacted with the anti-HA antibody (a-HA) or an anti-C-MYC antibody (a-C-MYC). The 1/5 or 1/20 volume of AM416 cell extract used for binding reaction were electrophoresed in parallel in the same gel (lanes AM416 on left and right, respectively). (E) The extract of HeLa cells was analysed as in (D) using the anti-C-MYC antibody and an anti-AMY-1 antibody (a-AMY-1). The 1/10 or 1/50 volumes of HeLa cell extract used for binding reaction were electrophoresed in parallel in the same gel (left or right of lane HeLa, respectively). (F) The wild-type and various deletion mutants of c- myc were expressed in the yeast cells transformed with pGBT9-AMY-1, and the interaction between myc proteins and AMY-1 was tested as in (A).

Journal: Genes to cells : devoted to molecular & cellular mechanisms

Article Title: AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC.

doi: 10.1046/j.1365-2443.1998.00206.x

Figure Lengend Snippet: Figure 6 Binding of AMY-1 to C-MYC. The whole length and various segments of the AMY-1 cDNA were expressed in yeast, in bacteria or in mammalian cells and the binding of the proteins to C-MYC was verified. (A) The whole length, the N-terminal half (ES; amino acids 1–63), the C-terminal deletion (EH; amino acids 1–89), the C-terminal half (SX; amino acids 64–104) and the C-terminal end (HX; amino acids 90–104) segments, schematically shown in the figure, were cloned in pGADGH and expressed in the S. cerevisiae HF7C cells (Clontech) transformed with pGBT9-c-myc. After incubation in liquid medium or on filters, b-galactosidase activity was assayed. (B) The wild-type and deletion mutants of AMY-1 fused to thioredoxin (Trx) and (His)6, as well as Trx-(His)6 alone, were expressed in E. coli and subjected to in vitro binding assays. The 1/20 volume of HL60 cell extract used for binding reaction was electrophoresed in the same gel in parallel (lane HL60). (C) The wild-type AMY-1 and the pocket domain of p107 which was fused to GST, as well as GST alone, were expressed in E. coli, purified, and subjected to in vitro binding assay by use of 35S-labelled C-MYC which was synthesized in vitro in reticulocyte lysate. The 1/100 volume of 35S-C-MYC used for the binding reaction was electrophoresed in the same gel in parallel (lane C-MYC). (D) The extract of AM416 cells, constitutively expressing AMY-1-HA, was first immunoprecipitated with an anti-HA antibody (a-HA) or nonspecific mouse IgG (IgG). The precipitates were then separated in a 7.5% polyacrylamide gel containing SDS, blotted on to a filter and reacted with the anti-HA antibody (a-HA) or an anti-C-MYC antibody (a-C-MYC). The 1/5 or 1/20 volume of AM416 cell extract used for binding reaction were electrophoresed in parallel in the same gel (lanes AM416 on left and right, respectively). (E) The extract of HeLa cells was analysed as in (D) using the anti-C-MYC antibody and an anti-AMY-1 antibody (a-AMY-1). The 1/10 or 1/50 volumes of HeLa cell extract used for binding reaction were electrophoresed in parallel in the same gel (left or right of lane HeLa, respectively). (F) The wild-type and various deletion mutants of c- myc were expressed in the yeast cells transformed with pGBT9-AMY-1, and the interaction between myc proteins and AMY-1 was tested as in (A).

Article Snippet: A single band was detected at 64 kDa with a mouse antiC-MYC antibody (C-33, Santa Cruz) in the samples recovered from the resin carrying the Trx-fusion proteins with the full-length (AMY) or the C-terminal half segment of AMY-1 (AMY(SX)), respectively, as well as in the HL60 nuclear extract, but not in the q Blackwell Science Limited Genes to Cells (1998) 3, 549–565 555 samples from the Trx-fused N-terminal half segment of AMY-1 (AMY(ES)) or Trx alone (Fig. 6B).

Techniques: Binding Assay, Bacteria, Clone Assay, Transformation Assay, Incubation, Activity Assay, In Vitro, Synthesized, Expressing, Immunoprecipitation